A significantly higher proportion of osteosarcoma specimens from patients with metastatic disease demonstrated expression of CD49b compared with specimens from patients without metastatic disease (75.0% vs. 49.3%, p=0.039). This evidence concerns the gene ITGA2 and metastatic neoplasm.